期刊名称:BIOCHEMICAL JOURNAL

ISSN:0264-6021
版本:SCI-CDE
出版频率:Semi-monthly
出版社:PORTLAND PRESS LTD, 1ST FLR, 10 QUEEN STREET PLACE, LONDON, England, EC4R 1BE
  出版社网址:http://www.biochemj.org/bj/default.htm
期刊网址:http://www.biochemj.org/bj/default.htm
影响因子:3.857
主题范畴:BIOCHEMISTRY & MOLECULAR BIOLOGY

期刊简介(About the journal)    投稿须知(Instructions to Authors)    编辑部信息(Editorial Board)   



About the journal

 

The Biochemical Journal invites you to submit your next paper online using the simple and straightforward instructions available at http://www.biochemj.org/submit

Immediate Publications - manuscripts are published online in pdf format as soon as they are accepted, approximately 9 weeks before they appear in an issue.

With no page charges, the impact factor up and fast acceptance to publication, why not submit your next paper to the Biochemical Journal?

The Biochemical Journal publishes over 6000 pages of high-quality scientific information every year. The papers are carefully selected by an international editorial board chaired by Peter Parker (London) to cover all aspects of biochemistry, and cell and molecular biology. The Vice-Chair (the Americas) is Guy Salvesen (La Jolla), and the Reviews Editor is John D. Scott (Portland, OR). The editorial board is supported by an international Editorial Advisory Panel

The journal features regular papers, authoritative highly cited reviews (impact factor 29.4*), commentaries where invited authors comment on the latest research published in the journal, and accelerated publications (highly cited articles reporting novel and significant findings). Accelerated Publications (impact factor 6.1*) are reviewed in two weeks and are fast-tracked for publication. The first colour figure will be printed free of charge (a saving of £550).

Biochemical Journal Online consists of full text and graphics in both HTML and PDF formats for all articles from Volume 313, part 1 (1 January 1996) onwards as well as HTML abstracts from Volume 153, part 1 (1 January 1976) onwards.

An Email current awareness service is available to all users. The journal features multimedia adjuncts and inter-journal linking and appears online one week earlier than the printed version.

Queries and correspondence from Authors in the Americas should be addressed to Dr Sharon Schendel, Administrative Editor, BJ USA Editorial Office, La Jolla, CA, USA., telephone +1 (858) 713 6283; fax: +1 (858) 713 6284; email: Editorial@biochemjusa.org

Queries and correspondence from Authors in the rest of the world should be addressed to Pauline Starley, Publisher, Biochemical Journal, 59 Portland Place, London W1B 1QW, U.K., telephone (U.K.) 020-7637 5873, (from overseas) +44 20 7637 5873; fax (U.K.) 020-7323 1136; (from overseas) +44 20 7323 1136; email editorial@portlandpress.com

Please note that both the La Jolla and the London Editorial Offices will be closed from 22 December 2003 to 4 January 2004 inclusive.

 

 


Instructions to Authors

 

POLICY AND ORGANIZATION OF THE JOURNAL

ONLINE SUBMISSION OF PAPERS

ACCEPTED PAPERS

NOMENCLATURE, STYLE AND CONVENTIONS

 

POLICY AND ORGANIZATION OF THE JOURNAL

General policy

The Biochemical Journal publishes papers in English in all fields of biochemistry and cellular and molecular biology, provided that they make a sufficient contribution to biochemical knowledge. Papers may include new results obtained experimentally, descriptions of new experimental methods of biochemical importance, or new interpretations of existing results. Novel theoretical contributions will be considered equally with papers dealing with experimental work. All work presented should have as its aim the development of biochemical concepts rather than the mere recording of facts. Preliminary, confirmatory or inconclusive work will not be published. The Biochemical Journal will not publish material that has been wholly or largely published elsewhere, even as a preliminary communication or in unrefereed symposium proceedings or on the World Wide Web (WWW); equally, fragmentation of research into `least publishable units' is discouraged.

The Journal places emphasis on the provision of quantitative data, with appropriate statistical analysis wherever possible.

The interpretation of this policy is in the hands of the Editorial Board, who judge whether each paper submitted is acceptable in terms of science and presentation.

Biochemical Journal Immediate Publications

PDFs of manuscripts are mounted on the Journal's website as Biochemical Journal Immediate Publications as soon as they are accepted, unless on submission the author has requested that this not be done. Biochemical Journal Immediate Publications are listed in and accessible through Medline, and are freely available to anyone with Internet access.

Biochemical Journal Online (http://www.BiochemJ.org)

Access to papers published in the Biochemical Journal Online in 2003 is restricted to institutions that have a subscription. To ensure that you have access, ask your subscribing librarian to contact subscriptions@portland-services.com. An electronic back archive is freely available to all users with Internet access.

Authors are encouraged to set up a hot-link from their home page to the abstract of their paper published in the online journal.

Medline links and inter-journal linking

The Biochemical Journal Online provides links to the Medline citations, to related papers in Medline, to Medline citations for downloading to citation management software, and from references to the relevant abstracts in other online journals.

Multimedia adjuncts

The Biochemical Journal Online offers authors the opportunity to enhance their papers with the multimedia adjuncts (e.g. time-lapse movies, three-dimensional structures). These will be submitted to peer review alongside the manuscript. To submit a paper with a multimedia adjunct, attach the file when you submit your manuscript online. Preferred formats are QuickTime for time-lapse movies and PDB for structures. There is no extra charge associated with the publication of a multimedia adjunct online.

Declaration of financial interests

Authors are strongly encouraged to disclose all relevant financial interests and sources of research funding that could be perceived to compromise the integrity of their article published in the Biochemical Journal.

Copyright policy

The Biochemical Journal is published by Portland Press Ltd on behalf of the Biochemical Society, the sole owner of the journal.The Biochemical Society makes a high degree of investment in the scientific publication process. Therefore it is our practice, together with most other Learned Societies, to ask you to assign the copyright of your paper if it is accepted for publication. There are also a number of practical reasons for this: (i) our ownership of copyright will ensure maximum international protection against infringement, libel or plagiarism; (ii) it will enable us to deal efficiently with requests from third parties to reproduce or reprint the article, or part of it.

In assigning your copyright you will not be forfeiting your proprietary rights, including your patent rights. You may also do the following after obtaining our permission (which would not be withheld unreasonably) and provided that the Journal is acknowledged as the original source:

  • revise, adapt, prepare derivative works, present orally or otherwise make use of the contents of your article;
  • make photocopies of all or part of the work provided that such copies are only used for teaching purposes within your institution and that no charge is made for such copies;

mount the PDF file of the electronic version of your article on your personal Web site, provided you include the following statement: "Mounted on the Internet with permission from the Biochemical Society (year of publication)". If you do not know how to do this, contact support@portlandpress.com (for general terms and conditions for use of the journal online,

Authors who are US Government employees, and whose works are therefore not subject to copyright protection, and employees whose works are subject to Crown copyright, will be asked to sign a non-exclusive licence. Full details will be provided on the Copyright Transfer Agreement that you will be asked to sign after your article is accepted for publication.

Portland Press books
Authors, Editors and all contributors to Portland Press journals may order books published by Portland Press, for their personal use, at 25% discount. A complete list of books can be found at http://www.portlandpress.com

Editorial offices

The editorial offices are part of Portland Press Ltd., the publishing division of the Biochemical Society, and administers all aspects of the processing, subediting and printing of the Biochemical Journal. The Chairman of the Editorial Board, on behalf of the Editorial Board, takes responsibility for the journal's content.

Addresses for correspondence

¡¤  Correspondence about papers from the USA, Canada, Mexico and Central and South America should be sent to:

Dr Sharon Schendel, Administrative Editor
BJ USA
The Burnham Institute
10901 N Torrey Pines Road
La Jolla
CA 92037
USA
telephone +1 858 713 6283
fax +1 858 713 6284
e-mail editorial@biochemjusa.org

¡¤  Correspondence about papers from all other countries, proofs and requests for permission to reproduce material should be addressed to:

The Managing Editor
Biochemical Journal
59 Portland Place
London W1B 1QW
U.K.
telephone (U.K.) 020-7637 5873
(from overseas) +44 20 7637 5873
fax (U.K.) 020-7323 1136

(from overseas) +44 20 7323 1136
e-mail
editorial@portlandpress.com

¡¤  All correspondence about offprints should be addressed to:

Offprint Department
Biochemical Journal
59 Portland Place
London W1N 3AJ
U.K.
telephone (U.K.) 020-7580 5530
(from overseas) +44 20 7580 5530
fax (U.K.) 020-7323 1136
(from overseas) +44 20 7323 1136
e-mail
editorial@portlandpress.com

¡¤  All correspondence about subscriptions to the journal, claims and back issues should be addressed to:

Portland Customer Services
P.O. Box 32
Commerce Way
Colchester CO2 8HP
U.K.
telephone (U.K.) 01206-796351
(from overseas) +44 1206 796351
fax (U.K.) 01206-799331
(from overseas) +44 1206 799331
e-mail
sales@portland-services.com

The Editorial Board and the Editorial Advisory Panel

Members of the Editorial Board, which is international, are appointed by the Executive Committee of the Biochemical Society on the recommendation of the Editorial Board. The composition of the Board is such that there is a wide range of expert opinion covering most areas of biochemical research.

The Editors are supported by an international panel of some 400 Editorial Advisers. These are independent reviewers, who are expert each in their own specific field of biochemistry, and who review up to ten papers a year for the journal. The close association of the Advisers with the journal means that a high standard of reviewing can be maintained.

Editors normally serve for a period of 3 years, although this may be extended for a further 4 years in some cases. The composition of the Advisory Panel is reviewed each year. The names of the members of the Editorial Board are published in each issue of the journal; those of the members of the Advisory Panel appear in part 2 of each volume.

Authors may suggest potential reviewers for their paper in the letter of submission, but the journal will usually regard such suggestions as a guide only and is under no obligation to follow them. Authors may also specify the names of those they wish to be excluded from the review process for a particular paper; in such cases their wishes are usually respected, unless, of course, in the opinion of the journal such a request unreasonably excludes all the expertise available to it in that scientific area.

Handling of papers

Copies of submitted papers are sent simultaneously to a selected Adviser (or, occasionally, to another independent reviewer) and to a relevant Editor. The Adviser (or other reviewer) assesses the paper and sends a report directly to the Editor by a date stipulated by the editorial office. The Editor will, in the meantime, have reached an independent judgement and, on receipt of the report, compiles a combined editorial report based on both opinions. In some cases, Editors will seek further advice from other scientists, and the report then reflects the views of all consulted. If the Editor and Adviser disagree, even after direct discussion, a second Editor is asked for an opinion and, if need be, a further Adviser. This may also be done when review of a paper demands expertise in more than one field of biochemistry. All papers are therefore seen by at least two independent scientists, and sometimes by more. The time taken for review is monitored by the editorial office, so that the policy of the journal to give authors rapid decisions is sustained.

When a paper is judged to have scientific merit and thus to be basically acceptable, the editorial office sends an appropriate letter to the authors together with an editorial report containing comments for the authors' consideration. After revision by the author the paper is checked by an Editor before being finally prepared for press by the subeditors. After typesetting, proofs are supplied to authors (except for Accelerated Publications) for correction of printer's errors only. Information regarding the purchase of offprints will be provided on a form supplied with the proofs; no free offprints are available.

If a paper is to be declined, the reports and correspondence are seen by the Chairman or one of the Deputy Chairmen, who then writes an explanatory letter to the authors. Papers may be declined for several reasons. They may, in the opinion of the reviewers, be unsatisfactory scientifically in that the methodology is open to criticism or that the conclusions are not sufficiently supported by the evidence presented. They may contain material that is, in principle, of interest but which is not clearly expounded; many papers suffer from being overlong, with the result that the salient points are not as clear to the reader(s) as to the author(s). They may be sound but only of peripheral biochemical interest and thus of more relevance to another discipline. Finally, and often most contentiously, they may represent an insufficient advance in knowledge. It cannot be overemphasized that, because of pressure for space in the journal, scientific soundness alone is not sufficient reason for publication of a paper: it must represent a definite and significant contribution to the field of study. Thus, in general, preliminary or confirmatory papers, or those reporting the existence of well-known biochemical processes in sources not previously studied, will not be accepted.

The Chairman's, or Deputy Chairman's, letter will set out the reasons why a paper has been declined and will indicate whether this decision is a final one or whether suitable revision might improve the paper sufficiently for it to be reconsidered. In this latter instance, encouragement for resubmission does not imply that a revised version will necessarily be accepted. In all cases the decision of the Chairman of the Editorial Board will be final.

If a paper that is returned to the authors for amendment, for whatever reason, is not resubmitted within 3 months (1 month for Accelerated Publications) it will be treated as a new paper and the date of receipt will be altered to the date of resubmission.

It is accepted that the reviewers may from time to time come to decisions that are not easily accepted by authors. This may be because of a conflict of opinion or, for example, and as frequently happens, because the authors' point is felt by the reviewers to be obscured by the presentation. The journal is always willing to hear from authors and to consider their views sympathetically. Appeals against decisions will always be considered by the Editorial Board. In rare cases, and if the reviewers and the Chairman agree, the usual anonymity of the reviewers may be set aside to allow discussion between all parties concerned.

ONLINE SUBMISSION OF PAPERS

Submission of a paper to the Biochemical Journal implies that it has been approved by all the named authors, that all persons entitled to authorship have been so named, that it reports unpublished work that is not under consideration for publication elsewhere, that conflicts of interest are declared and that if the paper is accepted for publication the authors will transfer to the Biochemical Society the copyright of the paper, which will then not be published elsewhere in the same form, in any language, without the consent of the Society. Authors will be required to sign an undertaking to these effects.

Easy Steps to submission as PDF

Step 1. Prepare the text in Microsoft Word 6.0 or a later version. Do not use Asian fonts as this will make your manuscript unreadable for reviewers. Use standard fonts such as Times or Times New Roman and symbol font for Greek and other special characters.

Step 2. Prepare graphics at publication quality resolution, using applications capable of generating high resolution TIFF or EPS files. Number each figure.

Step 3. Using Adobe Acrobat (see http://adobe.com/products/main.html for information), save your manuscript text and graphics in a single file in PDF format with one and a half line spacing. The PDF file should be printed and carefully reviewed before final submission. It is this version that is circulated on the Web for review. For detailed information on how to generate a PDF file go to http://www.biochemj.org/bj/submitpdf.htm. Step 4. After converting your manuscript text and figures to a single PDF file, carefully review a printed copy. Check file size (about 1 MB or less, but should not exceed 5 MB). If the file size exceeds 5 MB, please see http://www.biochemj.org/bj/submitpdf.htm for suggestions.

Step 5. Submit the necessary information using the submission template at the web site http://www.biochemj.org/submit. You will need:

  • Contact information for the Submitting Author
  • Information about the authors and the manuscript
  • A cover letter
  • The text and graphic PDF file for your manuscript with one and a half line spacing.

Submission not in PDF Format

If you cannot submit your manuscript as a PDF file, you may submit separate text and graphics files online. We will only accept the text of your manuscript as a Microsoft Word file created with MS Word 6.0 or a later version. Other word processing programs will not work for review. Do not use Asian fonts as this will make your manuscript unreadable for reviewers. Use standard fonts such as Times or Times New Roman and symbol font for Greek and other special characters. Do not embed figures in the text and be sure the number of the figure is visible in the figure. The MS Word and graphics files will be converted into a PDF file by the Editorial Office. However, you will be asked to approve the electronic version of the manuscript after the conversion to PDF. Carefully review a printed copy for changes in figures, formatting and symbols. A delay in review will occur if corrections are necessary because the manuscript must be resubmitted.

At this stage in the submission process we will accept graphics saved as TIFF, EPS, GIF, JPEG or BMP files. For graphics, we cannot accept certain application programs such as Microsoft Office (PowerPoint, Word, Excel, Access), Corel Perfect Office (WordPerfect, Quattro Pro, Presentations), Lotus SmartSuite (Freelance Graphics, 1-2-3, Approach, WordPro) and SigmaPlot. However, most of these applications will allow you to save graphics in one of the above formats.

General requirements

The main way in which authors can contribute to shortening the time between receipt and publication of a paper is to follow the requirements and suggestions in these Instructions to Authors, and to write in a concise style, although sufficient information must always be included to permit repetition of the experimental work and to support the conclusions that are drawn. Papers containing prolix or repetitive text or unnecessary Figures or Tables will always be returned for revision, with consequent delay in publication. Fragmentation of research into the `least publishable unit' should be avoided, and authors considering the submission of a series of papers on the same topic, which usually involves some degree of repetition, should consider whether appropriate combination of two or more papers could be achieved without loss of clarity of presentation.

The Biochemical Journal publishes papers in all fields of biochemistry and cellular and molecular biology; therefore it is important that papers on specialized subjects should be written in such a way that their approach and conclusions are intelligible to the informed, but non-specialist, reader of the journal.

The Editorial Board reserves the right to reject papers that cannot adequately be assessed because of a poor standard of English.

Format of papers

Before preparing papers, authors should consult a current issue of the journal to make themselves familiar with the general format, such as the use of cross-headings, layout of Tables and citation of references.

The full title should be concise but informative enough for use in coding for information storage and retrieval; it should not contain abbreviations other than the accepted ones listed in Table 1. Papers should also be headed by the authors' names (with one forename in full for each author, other forenames being given as initials) and by the name and full postal address (including postal code) of the establishment(s) where the work was done. The e-mail address ot the corresponding author will be published, unless requested otherwise. If there is more than one establishment involved in the work, authors' names should be linked to the appropriate establishment by the use of symbols *, †, ‡, ¡ì, and ¶ in that order. A short (page heading) title of up to 75 characters (but not containing any abbreviations other than those listed in Table 1) should also be suggested.

Separate papers in a series should not be numbered, but subtitles may be used.

The synopsis should be of less than 250 words (60 words for Accelerated Publications) and normally only 3¨C4% of the length of the paper. It should be as informative as possible, but should not contain inessential details or material not described in the body of the paper. References quoted in the synopsis must be given in full (surnames of all authors, year of publication, name of journal, volume number, inclusive pagination), and must not form part of the numbered reference system. Up to six keywords, of which at least three do not appear in the title, should be provided.

The main body of the paper should be divided into: (a) introduction; (b) experimental, including materials and methods; (c) results, with appropriate quantification and statistical treatment of data; (d) discussion; (e) acknowledgements, including details of financial support and declarations of interest (if any); (f) numbered references; (g) Tables and Figures. It is often an advantage to combine (c) and (d) with gains of conciseness and clarity. The discussion section should not recapitulate the results, but only discuss their implications. The number of references should not normally exceed 50, and 20¨C30 references are frequently adequate.

Authors may find it helpful to know that a full page of text in the Biochemical Journal contains approximately 1200 words. When calculating the printed length of papers, allowance must be made for the space taken up by insertions such as Figures, Tables and Schemes, and this is best assessed by inspection of similar insertions in a recent copy of the journal. A quick method of estimating the printed text length of typescripts is to add the number of pages (including references, but not Figure or Table legends) to the number of Figures and Tables and divide the total by 4. This assumes double-spaced typing in A4 format with normal margins.

Procedure for submission

Types of paper

1. Research Papers are the normal form of publication, and may be of any length that is justified by their content. Authors should, however, note that no paper, whatever its scientific merits, will be accepted if it exceeds the minimum length required for precision in describing the experiments and clarity in interpreting them. As a guide, most Research Papers are of between six and eight printed pages. A concise well-written paper tends to be published more quickly. To allow the reviewers to assess possible overlap with previous work, all papers must be accompanied by duplicate copies of the author's relevant published work, including that on the WWW, and of all related papers that are in press or under editorial consideration in this or other journals. Failure to do so may seriously delay evaluation of the paper.

2. Accelerated Publications (APs) are short papers (normally no more than four printed pages) bringing particularly novel and significant findings to the attention of the research community. It is intended that a decision on acceptance or rejection will be made within 10 working days of receipt, and publication of accepted APs in an issue will follow within 2 months. APs receive full but accelerated reviewing. The criteria of `novelty and significance' are strictly enforced, and papers may be rejected solely on the grounds of lack of novelty and significance. APs are not a path to accelerated publication of sound but non-urgent material. Papers reporting nucleotide sequences only are not acceptable as APs.

APs should be arranged in the usual style for a Biochemical Journal paper (synopsis, introduction, methods, results and discussion, with sufficient experimental detail to permit repetition of the work) and should not normally be longer than four printed pages of the journal [about 4000 words (24000 characters) of uninterrupted text, including references, but this number should be decreased to allow for the space taken up by Figures and Tables]. Papers submitted as APs that clearly exceed this length will be treated as Research Papers and the authors informed. The online submission procedures outlined above for Research Papers should be followed. The covering letter must contain a brief statement of why it is believed that the paper merits accelerated treatment.

The first colour figure in an AP is published free of charge (a saving of ?00); subsequent colour figures in the same paper cost ?00 each

3. Reviews will usually be solicited, although unsolicited reviews will be considered for publication. Prospective authors should first consult the Reviews Editor, via the London or La Jolla editorial office, and should enclose a short (one page) summary of the area they propose to cover.

Submission checklist

¡¤         Covering letter (including justification for Accelerated Publications)

¡¤         Master electronic copy of typescript, as one one and a half-line-spaced PDF

o        complete text in appropriate style, pages numbered

o        names (including forenames) and addresses of authors

o        name, address, telephone and fax numbers and e-mail address of corresponding author (all correspondence and proofs will be sent to this author)

o        synopsis

o        short (page heading) title

o        keywords

o        abbreviations footnote

o        acknowledgements and declarations of interest (if any)

o        checked references in the Numbering System

 

o        Tables, with titles and legends

o        Figure legends, with titles

o        artwork

¡¤         Related papers in press or under editorial consideration

¡¤         Evidence of approval of personal communications

¡¤         Evidence of submission of nucleic acid sequences to an appropriate data bank

ACCEPTED PAPERS

On acceptance authors will be requested to supply a diskette of the final version of their paper to the editorial office. Every effort will be made to use the diskette during typesetting, but this cannot be guaranteed. Authors must ensure that files have been updated to incorporate all revisions, and hence that the version on the diskette matches the revised hard copy. Our preferred word-processing format is Word for Windows version 6. Submission of manuscripts in other word-processing formats may lead to delays in processing. The diskette should be accompanied by a covering letter specifying manuscript number, operating system and software program.

Text

Files should be formatted double-spaced with no hyphenation and automatic wordwrap (no hard returns within paragraphs). Please type your text consistently, e.g. take care to distinguish between `1' (one) and `l' (lower case L), and `0' (zero) and `O' (capital O), etc. Do not use endnote/footnote formats. Text revisions must not be marked in the electronic copy.

Tables

Tables should be typed as text. The use of graphics programs and `table editors' should be avoided.

Figures

No artwork should be incorporated into the text files. Figures are normally handled conventionally, but artwork may be provided on disk either in TIFF or EPS format and saved as a separate file (for technical specifications see 'Notes for Contributors - Artwork' at http://uk.cambridge.org/information/authors/science/artwork.htm). Hard copy of illustrations must also be supplied.

Mathematics

In-line equations should be typed as text. The use of graphics programs and `equation editors' should be avoided. Displayed equations (unless prepared by the `MathType Equation Editor') are re-keyed by our printer.

NOMENCLATURE, STYLE AND CONVENTIONS

Abbreviations and symbols 5
Amino acids 5
Array data 5
Nucleosides, nucleotides and polynucleotides 5
Sugars 7
(Poly)phosphoinositides and their hydrolysis products 7
Animals 7
Biochemical nomenclature 7
Centrifugation 8
Density-gradient centrifugation 8
Ultracentrifuge data 8
Chemical nomenclature 8
Formulae 8
Ions 8
Naming compounds 8
Optically active isomers 8
Prefixes 8
Chromatography 8
Computer programs 8
Deposition of data 8
Electrophoresis 10
English style 10
Enzymes 10
Enzyme nomenclature 10
Enzyme units 10
Kinetic constants 10
Ethics 10
Animal experimentation 10
Human experimentation 10
Scientific publication 10
Experimental hazards 10
Footnotes 10
Gene nomenclature and symbols 10
'Homology' 10
Illustrations 10
Titles and legends 11
Lettering 11
Line diagrams 11
Histograms 11
Sequence diagrams 11
Half-tone illustrations 11
Colour figures 11
Isotopes 11
Units of measurement 11
Isotopically labelled compounds 11
Isotopically substituted compounds 12
Micro-organisms 12
Molecular mass and the dalton 12
Nucleotide sequences 12
Database addresses 12
Physical quantities and units 13
Plants 13
Powers in Tables and Figures 13
Prefixes for multiples and submultiples of units 14
Propagatable biological materials 14
Quantification of data 14
References and citations 14
URLs 14
Solutions 14
Description 14
Buffers 14
Spectra and spectroscopic data 14
Circular dichroism (CD) 15
Electron spin (paramagnetic) resonance (ESR/EPR) 15
Fluorescence spectroscopy 15
Infrared (IR) spectroscopy 15
Mass spectrometry (MS) 15
Mössbauer spectroscopy 15
Nuclear magnetic resonance (NMR) 15
Optical rotation 15
Visible and ultraviolet-absorption spectroscopy 15
Statistical treatment of results 15
Tables 16
Trademarks 16
X-ray crystallography 16

Abbreviations and symbols

The abbreviations listed in Table 1 are 'accepted', may be used without definition, and may be used in the title or the page-heading title. Other abbreviations, the use of which should be kept to a minimum compatible with clarity and conciseness, should not be used in the title or page-heading title and should be defined together in a footnote on the title page. In devising such abbreviations and symbols, the recommendations of the Nomenclature Committee of IUBMB and the IUPAC¨CIUBMB Joint Commission on Biochemical Nomenclature should be followed as far as practicable. The sections following summarize a number of these recommendations; all of the symbols listed may be used without definition.

Amino acids

The full residue names or the three-letter symbols are preferred to the one-letter symbols in the text (e.g. a phenylalanine residue at position 231 should be symbolized Phe-231 or Phe231 rather than F231). Either system may be used in sequences.

Alanine Ala A
Arginine Arg R
Asparagine Asn N
Aspartic acid Asp D
Aspartic acid or asparagine (undefined) Asx B
Cysteine Cys C
|
Cystine (half) Cys or Cys ¡ª
    |
Glutamine Gln Q
Glutamic acid Glu E
Glutamic acid or glutamine (undefined) Glx Z
Glycine Gly G
Histidine His H
Hydroxylysine Hyl ¡ª
Hydroxyproline Hyp ¡ª
Isoleucine Ile I
Leucine Leu L
Lysine Lys K
Methionine Met M
Ornithine Orn ¡ª
Phenylalanine Phe F
Proline Pro P
Serine Ser S
Threonine Thr T
Tryptophan Trp W
Tyrosine Tyr Y
Unknown or 'other' Xaa X
Valine Val V

The abbreviations kb (kilobases), nt [nucleotide(s)] and bp [base-pair(s)] may be used in discussions of nucleic acid sequences without definition.

The use of a single symbol to designate a variety of possible nucleotides at a single position has become widespread. The following set of symbols, applicable to both DNA and RNA, has been recommended. These symbols do not discriminate between DNA and RNA, and the symbol T is used at all positions where U might appear in the RNA. Sequences may be assumed to have a deoxyribose phosphate (DNA) backbone unless otherwise specified; in circumstances where confusion between DNA and RNA is possible, the sequence may be prefixed with the lower-case letter d or r.

    G guanine S G or C
    A adenine W A or T
    T thymine H A or C or T
    C cytosine B G or T or C
    R G or A V G or C or A
    Y T or C D G or A or T
    M A or C N G or A or T or C
    K G or T

Sugars

These symbols are for use only in representing polymers or sequences and in Tables and Figures:

    Ara Arabinose Glc Glucose
    dRib 2-Deoxyribose Man Mannose
    Fru Fructose Neu Neuraminic acid
    Fuc Fucose Rib Ribose
    Gal Galactose Xyl Xylose

When it is necessary to indicate furanose or pyranose, the letter f or p after the saccharide symbol may be used: e.g. Ribf for ribofuranose.

The following suffixes may be used, also without definition, to indicate derivatives:

A for uronic acid (e.g. GlcA for glucuronic acid, GalA for galacturonic acid)
N and NAc for 2-amino-2-deoxysaccharides and their N-acetyl derivatives (e.g. GlcN for glucosamine and GalNAc for N-acetylgalactosamine)

NeuAc or AcNeu suffices for N-acetylneuraminate.

Two systems (the extended and the condensed) exist for the representation of oligosaccharide chains. Either may be used.

In the extended system the configurational symbol ( or ) is included before the symbol for the monosaccharide, and is separated therefrom by a hyphen. The anomeric symbol ( or ) is included before the configurational symbol and separated therefrom by a hyphen. Between the symbol (abbreviated name) of one monosaccharide group or residue and the next are placed two locants that indicate the respective positions involved in this glycosidic union. These locants are separated by an arrow (directed from the locant corresponding to the glycosyl carbon atom to the locant corresponding to the carbon atom carrying the hydroxy group involved) and are enclosed in parentheses. The position of a branch is indicated above or below the main chain, with the numerals and an arrow indicating the glycosidic linkage:

should be unambiguously identified and the temperature of operation stated. The time of operation of the rotor at sustained plateau speed (ignoring initial rotor acceleration and deceleration periods) should be stated. For example: 'The rotor was operated for 15 min at 2 ¡ãC and 10000 g'.

Density-gradient centrifugation

The make of centrifuge and rotor used, the temperature of the run and the composition of the gradients should be stated. Results should preferably be plotted against distance from rotor centre rather than against fraction numbers; it is then unnecessary to indicate top and bottom of the gradient. If fraction numbers are used, the top and bottom of the gradient should be indicated.

Ultracentrifuge data

Sedimentation coefficient (not constant), s; sedimentation coefficient corrected at 20 ¡ãC in water, s20,w; sedimentation coefficient at zero concentration, s0, s; Svedberg unit (10¨C

 


Editorial Board

 

Chairman

P. J. Parker- London

Vice Chairman, The Americas

G. Salvesen- La Jolla

Reviews Editor

J. D. Scott- Portland, OR

Deputy Chairmen

G Banting - Bristol

D. N. Brindley - Edmonton

R. A. J. Challiss - Leicester

S Gutteridge - Newark

B. Henrissat - Marseille

N. M. Hooper - Leeds

J. P. Kehrer - Austin

K. H. Mayo - Minneapolis

M. J. O. Wakelam - Birmingham

M. P. Walsh - Calgary

Publisher

P. J. Starley

Senior Staff Editor

S. M. Hobday

Staff Editors

L. Ball

L. Johnson

J.M. Mockridge

N. B. Prowse

M. R. Thorne

Editorial Assistants

E. A. G. Elloway

L. M. Petty

Administrative Editor, US Office

S. Schendel

 

 

D. R. Alessi (Dundee)
D. Attaix (Ceyrat)
D. Barford (London)
G. J. Barritt (Adelaide)
P. G. Board (Canberra)
M Bogyo (Stanford, CA)
M. Bollen (Leuven)
N. C. Bruce (York)
B. Br¨¹ne (Kaiserslautern)
D.A. Cantrell (Dundee)
D. Carling (London)
S. J. Clark (Sydney)
A. Clerk (London)
G. M. Cohen (Leicester)
G. P. Côt¨¦ (Kingston, Ont.)
J. R. Couchman (London)
W. Cramer (West Lafayette)
G. J. Davies (York)
D. A. Day (Nedlands)
H. Deckmyn (Kortrijk)
M. A. Driscoll (Piscataway)
J. M. East (Southampton)
B. Engelmann (Munich)
R. M. Epand (Hamilton, Ont.)
B. Foxwell (London)
J-M Fr
èr
e (Liege)
M. J. Fry (Reading)
A. Galione (Oxford)
D. A. F. Gillespie (Glasgow)
S. Goodbourn (London)
S. V. Graham (Glasgow )
P. A. Grimaldi (Nice)
B. Hallberg (Ume?
P. I. Haris (Leicester)
L Hedstrom (Waltham, MA)
F.G. Hegardt (Barcelona)
S. High (Manchester)
M. B. Hodgins (Glasgow)
E. F. Hounsell (London)
J. Hsuan (London)
W. Jessup (Sydney)
B. Kalyanaraman (Milwaukee)
B. L. Knight (London)

 

 

I. M. Kovach (Washington, D.C.)
P. W. Kuchel (Sydney)
R. Leduc (Sherbrooke)
E.R. Levin (Long Beach, CA)
R. Liddington (La Jolla)
L. Machesky (Birmingham)
R Marais (London)
P. Maurel (Montpellier)
A. J. Meijer (Amsterdam)
M. Meisterernst (Munich)
H. Mellor (Bristol)
B. P. Morgan (Cardiff)
J. S. Mort (Montreal)
W. Muller-Esterl (Frankfurt)
J.H. Naismith (St. Andrews)
L. M. Obeid (Charleston)
M. Parenti (Monza)
M. A. J. Parry (Harpenden)
M. Paulsson (Cologne)
A. D. Postle (Southampton)
N. J. Pyne (Glasgow)
D. Ricquier (Paris)
G. A. Rutter (Bristol)
N. J. P. Ryba (Bethesda)
S.M. Schwartz (Seattle)
S.C. Sealfon (New York)
R. J. Simpson (Parkville)
B. F. Sloane (Detroit)
M. C. Sugden (London)
P. H. Sugden (London)
C.W. Taylor (Cambridge)
K. F. Tipton (Dublin)
M. A. Titheradge (Brighton)
A. B. Tobin (Leicester)
A. Toker (Boston)
S. A. Tooze (London)
M. Torti (Pavia)
H. M. Wallace (Aberdeen)
S. Ward (Bath)
J. F. Woessner (Miami)
S. J. Yeaman (Newcastle upon Tyne)
J York (Durham, NC)
S. Yoshikawa (Akoh-Hyogo


Copyright © 2014 武汉大学图书馆 版权所有